NeuExcell Therapeutics, Inc. to Present at the UBS Biotechnology Virtual Private Company Symposium
/PRNewswire/ -- NeuExcell Therapeutics, Inc., a preclinical gene therapy company focusing on improving the lives of patients suffering from neurodegenerative...
Ronald Lorijn Biotechnology Private Company Symposium Prnewswire Neuexcell Therapeutics Inc Virtual Biotechnology Private Company Symposium Excell Therapeutics Chief Executive Officer
Source: prnewswire.com